Literature DB >> 10208460

Assessment and diagnostic utility of the cytotoxic T-lymphocyte phenotype using the specific markers granzyme-B and TIA-1 in esophageal mucosal biopsies.

M B Resnick1, Y Finkelstein, A Weissler, J Levy, E Yakirevich.   

Abstract

Most esophageal intraepithelial lymphocytes (IELs) express T-cell markers. Increased numbers of esophageal IELs have been shown in reflux esophagitis. The cytotoxic potential and activity of esophageal IELs have not as yet been examined. Our objectives were to determine whether esophageal IELs express the recently described cytotoxic T-cell (CTLs) markers, TIA-1 and granzyme-B, and whether the number of CTLs correlates with well-defined endoscopic, clinical, and histological features of esophagitis. In this study, most CD-3+ esophageal IELs exhibit the CD-8+/TIA-1+ T cell with cytotoxic potential phenotype in both histologically normal biopsy specimens and in biopsy specimens with esophagitis. A subpopulation of esophageal IELs that express cytotoxic activity was identified by granzyme-B immunostaining. A significant positive association was found between the number of esophageal IELs seen by light microscopy in biopsy specimens with histological features of reflux (21 IELs/HPF) and Candida esophagitis (31 IELs/HPF) as compared with normal-appearing biopsy specimens (10 IELs/HPF) (P< or =.05). Furthermore, the number of TIA-1 or granzyme-B-positive IELs were significantly increased in biopsy specimens with reflux esophagitis (34 and 15 cells/HPF) and Candida esophagitis (44 and 18 cells/HPF) as compared with normal (11 and 2 cells/HPF) (P< or =.05). Granzyme-B and CD-3-positive IELs were also significantly elevated in biopsy specimens with reflux-associated squamous hyperplasia (P< or =.05). Finally, biopsy specimens of patients with dysphagia and to a lesser extent dyspepsia/heartburn exhibited increased numbers of IELs bearing the cytotoxic phenotype when compared with asymptomatic patients. In conclusion, we provide immunohistochemical evidence that most esophageal IELs exhibit the cytotoxic phenotype and that activated cytotoxic IELs are increased in reflux and Candida esophagitis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10208460     DOI: 10.1016/s0046-8177(99)90114-4

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  8 in total

Review 1.  Vaccinations for Anal Squamous Cancer: Current and Emerging Therapies.

Authors:  John Berry; Sean C Glasgow
Journal:  Clin Colon Rectal Surg       Date:  2018-11-02

Review 2.  How to Approach Lymphocytic Esophagitis.

Authors:  Anh D Nguyen; Kerry B Dunbar
Journal:  Curr Gastroenterol Rep       Date:  2017-06

3.  FibroScan in the Diagnosis of Hepatitis C Virus Infection.

Authors:  Nezam H Afdhal
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-08

4.  Evaluation of peripapillary lymphocytosis and lymphocytic esophagitis in adult inflammatory bowel disease.

Authors:  Benjamin Basseri; Eric A Vasiliauskas; Owen Chan; Hanlin L Wang; Robert J Basseri; Mark Pimentel; Edy Soffer; Jeffrey L Conklin
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-08

5.  Lymphocytic Esophagitis in Nonachalasia Primary Esophageal Motility Disorders: Improved Criteria, Prevalence, Strength of Association, and Natural History.

Authors:  Juan Putra; Kristen E Muller; Zilla H Hussain; Siddhartha Parker; Scott Gabbard; Elizabeth B Brickley; Brian E Lacy; Richard Rothstein; Mikhail Lisovsky
Journal:  Am J Surg Pathol       Date:  2016-12       Impact factor: 6.394

Review 6.  Lymphocytic esophagitis: Still an enigma a decade later.

Authors:  Carol Rouphael; Ilyssa O Gordon; Prashanthi N Thota
Journal:  World J Gastroenterol       Date:  2017-02-14       Impact factor: 5.742

7.  Squamous tissue lymphocytes in the esophagus of controls and patients with reflux esophagitis and Barrett's esophagus are characterized by a non-inflammatory phenotype.

Authors:  Alexandra Lind; Leo Koenderman; Johannes G Kusters; Peter D Siersema
Journal:  PLoS One       Date:  2014-08-29       Impact factor: 3.240

Review 8.  Intracellular versus extracellular granzyme B in immunity and disease: challenging the dogma.

Authors:  Wendy Anne Boivin; Dawn Michelle Cooper; Paul Ryan Hiebert; David James Granville
Journal:  Lab Invest       Date:  2009-09-21       Impact factor: 5.502

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.